University of California, Riverside

Graduate Medical Education



Clinical Faculty Biographies


Dr. David Franklin

Health Sciences Associate Clinical Professor - Psychiatry

Dr. David L. Franklin

Medical Offices

UCR Health - Citrus Tower
3390 University Avenue
Suite 115
Riverside, CA 92501
(844) 827-8000

Academic Office

School of Medicine
University of California, Riverside
Riverside, Calif. 92521
david.franklin@ucr.edu
If you are a patient, please do not use this email address.
Contact the medical office by telephone.

Education and Training

  • Internship, Neurology, University of California, Irvine, Irvine, California
  • Internship, Rehabilitation for Traumatic Brain Injury, Coastline Community College, Newport Beach, California
  • Psy.D., Clinical Psychology with an emphasis in Neuropsychology, Alliant International University, San Diego, California
  • M.S., Health Care Administration, California State University, Long Beach, Long Beach California
  • B.A., Psychology, Drake University, Des Moines, Iowa
Learn more about this clinical faculty member or schedule an appointment at UCRHealth.org

Biography

Dr. David Franklin, Psy.D., M.H.A., is a clinical neuropsychologist who joined the UC Riverside School of Medicine in 2014. He previously worked as an associate clinical professor at the UC Irvine School of Medicine and was director of resident and student wellness at the university.

Franklin received his master's of science in health care administration from California State University, Long Beach, and received his doctorate in clinical psychology with an emphasis in neuropsychology from Alliant International University.

He served as treasurer of the California Psychological Association Neuropsychology division. He has also worked as a consulting investigator/researcher for Clinical Innovations, Inc.

Research Interests

Franklin has conducted research in the use of Pagoclone, Olanzapine and Risperidone in the treatment of stuttering as well as on concussions and dementia. He was the assistant director of the UCI Stuttering Center and co-founding director of the UCI Comprehensive Sport Concussion Program.

Selected Publications

  • Maguire, GA, Franklin, DL, and Kristen, J. Assenapine in the treatment of Peer Stuttering: an analysis of three case reports. American Journal of Psychiatry. 2011 Jun;168(6):651-2.
  • Maguire, GA, Viele, SN, Argwal, S, Franklin, DL. Stuttering Onset associated with streptococcal infection: A case suggesting stuttering as PANDAS. Annals of Clinical Psychiatry. 2010 Nov;22(4):283-4.
  • Maguire G, Franklin D, Vatakis NG, Morgenshtern E, Denko T, Yaruss JS, Spotts C, Davis L, Davis A, Fox P, Soni P, Blomgren M, Silverman A, Riley G. Exploratory randomized clinical study of pagoclone in persistent developmental stuttering: the Examining Pagoclone for Persistent Developmental Stuttering Study. J Clin Psychopharmacol. 2010 Feb;30(1):48-56.
  • Jeffrey, Riley, Franklin, David; Choi, Vickie; Kim, Ronald; Binder, Devin; Cramer, Steven; Lin, Jack. Altered white matter integrity in temporal lobe epilepsy: association with cognitive and clinical profiles. Epilepsia. Dec. 2009. Ppg:1-10
  • Tran, N, Maguire, G, Franklin, DL, and Riley, G. Case Report with Aripiprazole in the Treatment of Adult Stuttering. Journal of Clinical Psychopharmacology. 2008 Aug;28(4):470-2
  • Maguire GA, Riley GD, Franklin DL, Maguire GE, Ortiz T, Maguire ME, Nguyen CT, Plon L, Rudkin S, Johnson TM, Yu BP, Plon LR, Gottschalk LA. Olanzapine in the Treatment of Adult Developmental Stuttering: A Double-Blind, Placebo-Controlled Trial Ann Clin Psychiatry. 2004 Apr-Jun;16(2):63-7.
  • Maguire GA, Yu BP, and Franklin DL. Alleviating stuttering with pharmacological interventions. Expert Opin Pharmacother. 2004 Jul;5(7):1565-71. Review
  • Maguire GA, Yu BP, Franklin DL, Ortiz T, Riley GD. New Therapies Can Help Patients who Stutter. Current Psychiatry May 2002
  • Riley G, Maguire G, Franklin D, Ortiz T. Medical Perspectives in the Treatment of Stuttering. Contemporary Issues in Communication Science and Disorders. Vol. 28. Fall 2001, pp. 104-110.
  • Gottschalk LA, Bechtel RJ, Maguire GA, Harrington DE, Levinson DM, Franklin DL, Carcamo D. Computerized Measurement of Cognitive Impairment and Associated Neuropsychiatric Dimensions. Comprehensive Psychiatry. Vol. 41, No. 5 (Sept/Oct), 2000: pp 326-333.
  • Maguire, G.A., Riley, G.D., Franklin, D.L., Wu, J.C., Ortiz, T, Plon, L, Johnson, T.M., Gottschalk, L.A. The Dopamine Hypothesis of Stuttering and Its Treatment Implications. The International Journal of Neuropsychopharmacology, Volume 3, Supplement 1, July 2000.
  • Maguire GA, Gottschalk LA, Riley GD, and Franklin DL. Risperidone in the Treatment of Stuttering. Journal of Clinical Psychopharmacology . 2000. Aug. 20(4):479-482.
  • Lavid N, Franklin DL, and Maguire G. Management of Child and Adolescent Stuttering with Olanzapine: Three Case Reports. Annals of Clinical Psychiatry, Vol. 11, #4, 1999.
  • Maguire GA, Gottschalk LA, Riley GD, Franklin DL, Bechtel RJ, and Ashurst J. Stuttering: Neuropsychiatric Features Measured by Content Analysis of Speech and the Effect of Risperidone on Stuttering Severity. Journal of Comprehensive Psychiatry. 1999. July-Aug. 40(4):308-314.
  • Maguire G, Riley G, Wu J, Franklin D, and Potkin S. Risperidone Treatment of Stuttering. In Speech Production: Motor Control, Brain Research and Fluency Disorders. W. Hulstijn, H.F.M Peters and P.H.H.M. Van Liesohout, eds. 1997 Elsevier Science. Pp 379-382
  • Kalali A, Franklin D, Carreon D, and Potkin S. Prevalence of Extrapyramidal Symptoms in Patients Treated Concurrently with Lithium and Seroquel. Schizophrenia Research Vol. 24, #1,2 March 1997.

More Information 

General Campus Information

University of California, Riverside
900 University Ave.
Riverside, CA 92521
Tel: (951) 827-1012

Department Information

Graduate Medical Education
2608 School of Medicine Education Building

Tel: (951) 827-7669

E-mail: medschool@ucr.edu

Footer